Acutus Medical News

BTIG Issues a Buy Rating on Acutus Medical (AFIB)

TipRanksApr 20, 2023 09:28 ET

BTIG Sticks to Its Buy Rating for Acutus Medical (AFIB)

TipRanksMar 22, 2023 16:26 ET

BTIG Sticks to Their Buy Rating for Acutus Medical (AFIB)

TipRanksMar 16, 2023 21:08 ET

BTIG Remains a Buy on Acutus Medical (AFIB)

TipRanksDec 21, 2022 09:30 ET

BTIG Keeps Their Buy Rating on Acutus Medical (AFIB)

TipRanksNov 10, 2022 22:20 ET

BTIG Sticks to Its Buy Rating for Acutus Medical (AFIB)

TipRanksNov 3, 2022 09:25 ET

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF) and Acutus Medical (AFIB)

TipRanksSep 28, 2022 06:10 ET

Acutus Medical Is Maintained at Neutral by Goldman Sachs

Dow JonesAug 16, 2022 08:35 ET

Acutus Medical Price Target Raised to $1.50/Share From $1.00 by Goldman Sachs

Dow JonesAug 16, 2022 08:35 ET

Acutus Medical Analyst Ratings

Benzinga Analyst RatingsAug 16, 2022 08:26 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Acutus Medical (AFIB)

TipRanksAug 11, 2022 22:35 ET

Acutus Medical (AFIB) Gets a Buy Rating from BTIG

TipRanksJul 22, 2022 05:25 ET

Acutus Medical (AFIB) Gets a Buy Rating from BTIG

TipRanksJul 1, 2022 09:22 ET

Acutus Medical Is Maintained at Buy by BTIG

Dow JonesJun 24, 2022 09:29 ET

Acutus Medical Price Target Cut to $1.50/Share From $2.00 by BTIG

Dow JonesJun 24, 2022 09:29 ET

Acutus Medical analyst ratings

Benzinga Analyst RatingsJun 24, 2022 09:20 ET

BTIG Maintains Buy on Acutus Medical, Lowers Price Target to $1.5

Benzinga Real-time NewsJun 24, 2022 09:20 ET

BTIG Adjusts Acutus Medical's Price Target to $1.50 From $2, Reiterates Buy Rating

MT NewswiresJun 24, 2022 09:08 ET